Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. of Cambridge, Mass., has expanded the activities of its Biomarker Research Initiative in Mass Spectrometry center. Originally created in cooperation with Massachusetts General Hospital in Boston to focus on protein biomarker discovery, the center now will conduct clinical validation and clinical application assays. Triple-quadrupole platforms from Thermo Fisher Scientific are being used to develop highly selective, multiple-reaction monitoring assays for peptide and protein biomarker quantitation.
- mass spectrometry
- An instrumental technique that utilizes the mass-to-charge ratio of charged particles as recorded from a mass spectrometer in order to determine the mass of a particle as well as the chemical makeup, or elemental ionic composition of a given sample or molecule.
MORE FROM PHOTONICS MEDIA